Гібридні Операції При Лікуванні Синдрому Гіпоплазії Лівих Відділів Серця

Truba, Iaroslav P.; Ditkivskyy, I. O.; Yashchuk, N. S.; Cherpak, B. V.; Golovenko, Oleksandr S.; Boyko, S. М.; Lazoryshynets, V. V.

doi:10.30702/css.201903.01.054561

ccs

2019

DOI: 10.30702/css.201903.01.054561

|View full text |Cite

Гібридні Операції При Лікуванні Синдрому Гіпоплазії Лівих Відділів Серця

Iaroslav P. Truba¹,

I. O. Ditkivskyy²,

N. S. Yashchuk³

et al.

Abstract: У статті проведено оглядове ознайомлення гібридного втручання при синдромі гіпоплазії лівих відділів серця (СГЛВС) як альтернативи традиційній операції Норвуд I у пацієнтів з групи високого ризику. Перший етап гібридної паліативної операції включає білатеральне звуження легеневої артерії (ЛА) та стентування відкритої артеріальної протоки (ВАП) через серединну стернотомію без застосування апарата штучного кровообігу (ШК). Другий етап гібридного паліативного лікування СГЛВС – це одночасне виконання операції Норв… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Tendencies congenital heart diseases surgical correction. Ten years experience of Amosov National Institute of Cardiovascular Surgery.

Lazoryshynets¹,

Ditkivskyy²,

Truba³

et al. 2021

Journal NAMSU

View full text Add to dashboard Cite

Aim: To analyze the experience of treatment of congenital heart disease. Identify the proportions and ratios of surgical and endovascular treatments. Development of diagnostic service. To determine the impact of industry funding mechanisms on the development of endovascular surgery for congenital heart disease. Materials and methods: The tendencies of cardiac surgery development of congenital heart defects on the basis of the analysis of endovascular and surgical methods of treatment are considered. Own results of 10 years of experience in the treatment of congenital heart disease are presented. Results: An increase in the proportion of endovascular methods and a decrease in surgical treatments. The obtained data show a rapid increase in the share of medical procedures (from 48.9% to 89.4%) and a sharp decline in the share of diagnostic procedures (from 51.1% to 10.6%) in endovascular surgery. Early mortality after cardiac surgery in children is <5%, mortality after edovascular interventions - <1%. Ultrasound examination (ultrasound) of the heart - allows to detect 95% of all congenital heart defects and is shown to every citizen as a screening method. The influence of industry financing mechanisms on the development of endovascular surgery of congenital heart defects is shown. Expensive equipment began to be purchased at public expense, the number of equipment representatives on the market increased and, as a result, the number of endovascular procedures increased. Over the past 5 years, public funding for the needs of the industry has increased from 16 to 75%. Conclusions: Today, pediatric cardiology and cardiac surgery are reaping the fruits of the golden age in medical science. With the development of cardiac surgery, the number of operated patients increases every year. The successful outcome of treatment of patients with CHD depends on a comprehensive multidisciplinary team (Heart Team). New evidence-based approaches in resuscitation management allow to recover as soon as possible after the intervention. We see further development of the industry in the development of multidisciplinary teams to help patients with the CHD. Finally, we expect an increase in the regulatory burden and the cost of developing new treatments and diagnostics. Key words: congenital heart defects, endovascular methods, open heart operations, minimally invasive interventions, critical heart defects.

show abstract

Tendencies congenital heart diseases surgical correction. Ten years experience of Amosov National Institute of Cardiovascular Surgery.

Lazoryshynets¹,

Ditkivskyy²,

Truba³

et al. 2021

Journal NAMSU

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Гібридні Операції При Лікуванні Синдрому Гіпоплазії Лівих Відділів Серця

Cited by 1 publication

References 6 publications

Tendencies congenital heart diseases surgical correction. Ten years experience of Amosov National Institute of Cardiovascular Surgery.

Tendencies congenital heart diseases surgical correction. Ten years experience of Amosov National Institute of Cardiovascular Surgery.

Contact Info

Product

Resources

About